Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparison of intradermal, subcutaneous, and intramuscular Stamaril yellow fever vaccination
2024-514154-73-00Phase 3Authorised
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Sep 2024
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of 17D yellow fever vaccine in yellow fever (3 arms), sponsored by Institute of Tropical Medicine Antwerp. Planned start Sep 2024; status: authorised.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on 2024-514154-73-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514154-73-00.